预防新冠病毒肺炎患者的心脏损伤。
Preventing cardiac damage in patients with COVID-19.
作者信息
Robson Andrew
机构信息
Nature Reviews Cardiology, .
出版信息
Nat Rev Cardiol. 2021 Jun;18(6):387. doi: 10.1038/s41569-021-00550-3.
Abstract
A cardiac organoid approach combined with phosphoproteomics and single nuclei RNA-sequencing identifies bromodomain and extraterminal family inhibitors as promising candidates to prevent COVID-19 mediated cardiac damage.
摘要
一种结合磷酸化蛋白质组学和单核RNA测序的心脏类器官方法，确定了溴结构域和额外末端结构域家族抑制剂是预防COVID-19介导的心脏损伤的有前景的候选药物。
Zotero 插件